Form 483

FUJIFILM Ultra Pure Solutions, Inc Form 483, 2017-01-12

FDA issued a Form 483 to FUJIFILM Ultra Pure Solutions, Inc on 2017-01-12 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

FUJIFILM Ultra Pure Solutions, Inc · Carrollton, United States · Issued January 12, 2017

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Jan 2017
21 CFR 211.165(e)

Test methods

Cited by Massoud Motamed

12 Jan 2017
21 CFR 211.188(b)

Batch production and Batch Control Record Requirements

Cited by Massoud Motamed

12 Jan 2017
21 CFR 211.22(a)

Lack of quality control unit

Cited by Massoud Motamed

12 Jan 2017
21 CFR 211.58

Buildings not maintained in good state of repair

Cited by Massoud Motamed

Inspected site

FUFUJIFILM Ultra Pure Solutions, IncCarrollton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.58Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere